<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250605066076N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-06-10</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Photobiomodulation on Pain Reduction After Miniscrew Placement in Orthodontics</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the Effectiveness of Photobiomodulation Therapy on Pain Reduction After Miniscrew Placement in Orthodontic Patients: A Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>18</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/84120</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Other design features: This study employs a split-mouth design, where each participant simultaneously receives both the intervention (active photobiomodulation) and placebo (inactive laser) on different sides of the mouth. This design minimizes inter-individual variability and enhances the precision of the results by allowing each participant to serve as their own control, Randomization description: Randomization is performed using two series of random numbers in blocks of 2, 4, and 6, generated via www.sealedenvelope.com. The first series determines the side of the mouth for intervention, and the second series determines the type of intervention (active laser or placebo). Allocation concealment is ensured using sealed opaque envelopes, each containing codes A or B. Randomization is conducted by an independent researcher not involved in treatment or assessment. Patient enrollment is performed by an orthodontist, and intervention allocation is conducted by a trained assistant, Blinding description: This study is designed as a double-blind trial. Participants are unaware of the intervention allocation (active laser or placebo) on each side of the mouth, as the laser device used for both active and placebo interventions has identical appearance, sound, and application procedure. Outcome assessors, responsible for evaluating pain using the Visual Analog Scale (VAS) and assessing the gingival index, are blinded to the intervention allocation, as data collection forms and clinical examinations do not indicate which side received the active or placebo treatment. Blinding is maintained through standardized laser application protocols and sealed randomization codes managed by an independent researcher. The clinical caregiver (orthodontist administering the intervention) and the data analyst are not blinded due to the requirements of intervention delivery and data analysis.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Pain following miniscrew placement in orthodontic treatment.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Photobiomodulation therapy using a diode laser with a wavelength of 940 nanometers, power of 300 milliwatts, and energy density of 31.7 joules per square centimeter in continuous wave mode, applied for 180 seconds to the tissue surrounding the miniscrew on one side of the mouth. The laser is administered with a spot size of 1.7 square centimeters, moving from the surrounding tissue toward the center, by a trained operator. Intervention 2: Control group: Placebo with an inactive laser applied for 180 seconds to the tissue surrounding the miniscrew on the opposite side of the mouth. The procedure mimics the active laser application in appearance, sound, and duration to maintain blinding, performed by a trained operator.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Individual Participant Data, Study Protocol, Statistical Analysis Plan, Informed Consent Form, Clinical Study Report, Analysis Codes, and Data Dictionary: The individual participant data (IPD) will include de-identified data on pain intensity (Visual Analog Scale scores), gingival index, inflammation, redness, and blisters, as well as demographic variables (age, gender) and pain catastrophizing scale scores. The study protocol will detail the methodology, including the split-mouth design, photobiomodulation parameters, and outcome assessments. The statistical analysis plan will describe the statistical tests (e.g., paired t-test, Wilcoxon, GEE) and software (SPSS) used. The informed consent form will be shared in its final approved version. The clinical study report will summarize findings post-study completion. Analysis codes will include SPSS syntax for all statistical analyses. The data dictionary will define all variables, their coding, and measurement units.

When:
Data and documents will be available starting six months after the publication of the primary study results and will remain accessible for five years thereafter.

To whom:
Researchers affiliated with academic or scientific institutions, including universities and research centers, who are conducting non-commercial research related to orthodontics, pain management, or photobiomodulation.

Conditions:
Data and documents may be used for secondary analyses, meta-analyses, or methodological reviews related to orthodontic pain management or photobiomodulation. Access requires a formal request outlining the research objectives, analysis plan, and ethical approval for the proposed study. Recipients must sign a data use agreement ensuring confidentiality, non-commercial use, and no attempt to re-identify participants. Data sharing will comply with ethical standards and Iranian regulations.

Where to obtain:
Requests should be submitted via email to Dr. Fatemeh Azizi at azizi3889@gmail.com. Alternatively, contact the Research Office at Kermanshah University of Medical Sciences, Shahid Beheshti Boulevard, Kermanshah, Iran, phone: +98 83 34276301.

How to obtain:
Applicants must submit a written request detailing the research purpose, analysis plan, and ethical approval. The request will be reviewed by the study’s principal investigator (Dr. Fatemeh Azizi) and the Kermanshah University of Medical Sciences Ethics Committee within four weeks. If approved, a data use agreement will be signed, and data/documents will be shared via a secure electronic platform within two weeks of agreement. Applicants will be notified of the decision and expected timeline.

Comments:
All shared data will be anonymized to protect participant privacy. The study team reserves the right to reject requests that do not align with the study’s ethical or scientific objectives. Shared data must not be redistributed without prior approval.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Perham Shirvani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Afshin Johari Alley, Namaz Blvd, Niayesh Square</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6715783197</zip>
        <telephone>+98 83 3421 8154</telephone>
        <email>parham.shirvani@kums.ac.ir</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Perham Shirvani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Afshin Johari Alley, Namaz Blvd, Niayesh Square</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6715783197</zip>
        <telephone>+98 83 3421 8154</telephone>
        <email>parham.shirvani@kums.ac.ir</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients requiring miniscrew placement during orthodontic treatment
No prior orthodontic treatment before the study
No radiographic evidence of bone loss
No active dental caries
No periodontal diseases
Adequate oral hygiene</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Hypersensitivity to laser light
Pregnancy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Photobiomodulation therapy using a diode laser with a wavelength of 940 nanometers, power of 300 milliwatts, and energy density of 31.7 joules per square centimeter in continuous wave mode, applied for 180 seconds to the tissue surrounding the miniscrew on one side of the mouth. The laser is administered with a spot size of 1.7 square centimeters, moving from the surrounding tissue toward the center, by a trained operator.</i_keyword>
      <i_keyword>Control group: Placebo with an inactive laser applied for 180 seconds to the tissue surrounding the miniscrew on the opposite side of the mouth. The procedure mimics the active laser application in appearance, sound, and duration to maintain blinding, performed by a trained operator.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity following miniscrew placement in orthodontic treatment. Timepoint: Immediately after miniscrew placement, 1 hour after miniscrew placement, 12 hours after miniscrew placement, 24 hours after miniscrew placement. Method of measurement: Visual Analog Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Gingival inflammation around the miniscrew placement site as measured by the modified gingival index, scored as: 0 (no inflammation, pink gingiva, no visible biofilm), 1 (mild inflammation, red gingiva without bleeding), 2 (moderate inflammation, severe red gingiva with mild bleeding on probing), 3 (severe inflammation or miniscrew failure, pronounced bleeding, swelling). Timepoint: 7 days after miniscrew placement. Method of measurement: Modified Gingival Index.</sec_outcome>
      <sec_outcome>Presence of redness around the miniscrew placement site. Timepoint: 7 days after miniscrew placement. Method of measurement: Clinical examination by an orthodontist.</sec_outcome>
      <sec_outcome>Presence of blisters around the miniscrew placement site. Timepoint: 7 days after miniscrew placement. Method of measurement: Clinical examination by an orthodontist.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-05-13</approval_date>
        <contact_name>Ethics Committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Ethics Committee, Medical Faculty, Daneshgah Street, Shahid Shiroodi Boulevard Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
